Results The study population was sex-balanced with a small predominance of women, who
were older than men. We observed reduction of age between the first and third time interval (…

Chronic hepatitis C (CHC) is generally a slowly progressive disease, but some factors
associated with rapid progression have been identified. Steatosis, independently of its metabolic …

Background & Aims Telaprevir plus pegylated interferon/ribavirin (TPV + PegIFN/RBV) remains
a therapeutic option for chronic hepatitis C virus (HCV) genotype (GT) 1 infection in many …

Air pollution can adversely affect the immune response and increase the severity of the viral
disease. The present study aimed to explore the relationship between symptomatology, …

Long-term analyses of demographical and clinical characteristics of COVID-19 patients can
provide a better overview of the clinical course of the disease. They can also help …

Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease
undergoing bariatric surgery

Wstęp: Ekspozycję zawodową na HIV definiuje się jako kontakt pracownika z materiałem
zakaźnym stwarzającym ryzyko zakażenia. Ryzyko zawodowej transmisji HIV jest niewielkie (0…

Background: Patients with kidney failure are at an increased risk of progression to a severe
form of coronavirus disease 2019 (COVID-19) with high mortality. The current analysis was …

Background Remdesivir (RDV) is the only antiviral drug registered currently for treatment of
COVID-19 after a few clinical trials with controversial results. The purpose of this study was to …

BACKGROUND Nearly 290000 patients with chronic hepatitis C die annually from the most
severe complications of the disease. One of them is liver cirrhosis, which occurs in about 20…